BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immune Sera

Below is an extended Immune Sera patents listing. Click here to return to the Immune Sera main in depth entry.

Patents :

US Patent No.Title
7405270 CD40-Ligand lacking native-pattern glycosylation
7411047 PRO6097 antibodies
7413851 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7413875 ESTs and encoded human proteins
7414112 Antibodies to PRO1550 polypeptides
7414123 Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
7414170 Transgenic bovines capable of human antibody production
7416839 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans
7417115 PRO6027 polypeptides
7417116 PRO7155 polypeptides
7417123 PRO4399 Antibodies
7411040 PRO6182 polypeptides
7411037 Polypeptides encoded by a nucleic acid underexpressed in melanoma
7410645 Moraxella (Branhamella) catarrhalis antigens
7407664 Peptide vaccines against group A streptococci
7408028 Peptides, antibodies thereto, and their use in treatment of central nervous system, damage
7408032 PRO1188 polypeptides
7408033 PRO5995 polypeptides
7408034 PRO20025 polypeptides
7408035 PRO9864 polypeptides
7408042 Anti-PRO6181 antibodies
7408048 Mammalian grainyhead transcription factors
7408053 Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby
7410642 Assays and therapies for latent viral infection
7417125 Antibodies that bind a PRO1158 polypeptide
7417126 PRO246 antibodies
7425605 PRO1486 polypeptides
7425607 Compositions comprising a lung tumor antigen
7425609 PRO4330 polypeptides
7425612 Genes and polypeptides relating to human colon cancers
7425613 PRO1375 polypeptides
7425621 Antibodies against the PRO4401 polypeptide
7427404 Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
7427664 Antibodies to polypeptides that stimulate TNF-.alpha. release
7427667 PRO9835 antibodies
7429640 PRO6181 polypeptides
7425447 Host cells expressing 7C10 and 16C10 CD80-specific antibodies
7425428 Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby
7425334 Methods of making antibodies that bind Nogo
7417128 7C10 and 16C10 CD80-specific antibodies
7419672 Genes and proteins, and their use
7419799 Compositions and methods for the treatment of immune related diseases
7420038 Compositions for controlling hair growth
7423119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
7423120 PRO19814 polypeptides
7423127 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
7423130 PRO1158 polypeptides
7423198 High oleic acid Brassica juncea
7425328 Tissue factor antibodies and uses thereof
7429641 PRO9830 polypeptides
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional